Osteosarcoma News and Research

RSS
Between two and three percent of all childhood cancers are osteosarcoma. Because osteosarcoma usually develops from osteoblasts, it most commonly affects children and young adults experiencing their adolescent growth spurt. Boys and girls have a similar incidence rate until later in their adolescence, when boys are more commonly affected. While most tumors occur in larger bones, such as the femur, tibia, and humerus, and in the area of the bone that has the fastest growth rate, they can occur in any bone. The most common symptom is pain, but swelling and limited movement can occur as the tumor grows.

Osteosarcoma is an orphan disease with approximately 1,200 new cases diagnosed in the United States each year. A similar incidence of the disease exists in Europe. According to the Children's Oncology Group (COG), the survival of children with osteosarcoma has remained at 60-65 percent since the mid-1980s. The standard treatment for osteosarcoma is tumor resection with combination chemotherapy before and after surgery.
Children born via IVF more likely to develop cancer later in life

Children born via IVF more likely to develop cancer later in life

Researchers conduct largest study of childhood cancer after conception by IVF

Researchers conduct largest study of childhood cancer after conception by IVF

New precision medicine treatment for bone cancer in dogs opens door for human clinical trials

New precision medicine treatment for bone cancer in dogs opens door for human clinical trials

New drug shows promise in treating sarcomas

New drug shows promise in treating sarcomas

Research may pave way for development of potent weapons against cancer

Research may pave way for development of potent weapons against cancer

Mannose - nutritional supplement, could slow some cancers

Mannose - nutritional supplement, could slow some cancers

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Nutritional supplement can slow cancer growth and enhance effects of chemotherapy

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Sugar supplement shown to slow tumor growth and enhance chemotherapy

Stand Up to Cancer supports potential approach to more efficiently target pancreatic cancer

Stand Up to Cancer supports potential approach to more efficiently target pancreatic cancer

Two major studies on canine cancers may provide clues on human cancers

Two major studies on canine cancers may provide clues on human cancers

Researchers successfully implant biomimetic hybrid prosthesis imitating bone structure

Researchers successfully implant biomimetic hybrid prosthesis imitating bone structure

Seattle Children's opens new clinic to provide convenient access to pediatric specialty care services

Seattle Children's opens new clinic to provide convenient access to pediatric specialty care services

Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer

Molecules formed when the body metabolizes omega-3 fatty acids may inhibit cancer

Scientists discover first genetic marker for bone tumor

Scientists discover first genetic marker for bone tumor

Researchers make key discovery about cellular pathway linked to myriad of diseases

Researchers make key discovery about cellular pathway linked to myriad of diseases

Virus-like particle could translate into new vaccine for cancer treatment

Virus-like particle could translate into new vaccine for cancer treatment

Scientists use novel epigenetic-centered techniques to inhibit cancer metastases

Scientists use novel epigenetic-centered techniques to inhibit cancer metastases

Targeted fluorescence successfully identifies pulmonary metastases in osteosarcoma patient

Targeted fluorescence successfully identifies pulmonary metastases in osteosarcoma patient

Researchers reveal how tumor cells disrupt circadian rhythm to survive

Researchers reveal how tumor cells disrupt circadian rhythm to survive

New cancer drug begins clinical trial in human patients with rare brain tumor

New cancer drug begins clinical trial in human patients with rare brain tumor